NO305122B1 - AnalogifremgangsmÕte ved fremstilling av kinolin-, naftyridin- og pyridobenzoksazinderivater - Google Patents

AnalogifremgangsmÕte ved fremstilling av kinolin-, naftyridin- og pyridobenzoksazinderivater

Info

Publication number
NO305122B1
NO305122B1 NO932176A NO932176A NO305122B1 NO 305122 B1 NO305122 B1 NO 305122B1 NO 932176 A NO932176 A NO 932176A NO 932176 A NO932176 A NO 932176A NO 305122 B1 NO305122 B1 NO 305122B1
Authority
NO
Norway
Prior art keywords
naphthyridine
quinoline
preparation
analogous process
pyridobenzoxazine derivatives
Prior art date
Application number
NO932176A
Other languages
English (en)
Norwegian (no)
Other versions
NO932176D0 (no
NO932176L (no
Inventor
Daniel T Chu
Curt S Cooper
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO932176D0 publication Critical patent/NO932176D0/no
Publication of NO932176L publication Critical patent/NO932176L/no
Publication of NO305122B1 publication Critical patent/NO305122B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO932176A 1990-12-12 1993-06-14 AnalogifremgangsmÕte ved fremstilling av kinolin-, naftyridin- og pyridobenzoksazinderivater NO305122B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/626,602 US5137892A (en) 1990-12-12 1990-12-12 Quinoline, naphthyridine and pyridobenzoxazine derivatives
PCT/US1991/009419 WO1992010191A1 (en) 1990-12-12 1991-12-12 Quinoline, naphthyridine and pyridobenzoxazine derivatives

Publications (3)

Publication Number Publication Date
NO932176D0 NO932176D0 (no) 1993-06-14
NO932176L NO932176L (no) 1993-06-14
NO305122B1 true NO305122B1 (no) 1999-04-06

Family

ID=24511084

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932176A NO305122B1 (no) 1990-12-12 1993-06-14 AnalogifremgangsmÕte ved fremstilling av kinolin-, naftyridin- og pyridobenzoksazinderivater

Country Status (8)

Country Link
US (1) US5137892A (zh)
EP (1) EP0562042A4 (zh)
JP (1) JP2546769B2 (zh)
AU (1) AU9175991A (zh)
IE (1) IE914115A1 (zh)
NO (1) NO305122B1 (zh)
TW (1) TW230774B (zh)
WO (1) WO1992010191A1 (zh)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US5541155A (en) * 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US6099856A (en) 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5693338A (en) 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US5443841A (en) * 1992-06-15 1995-08-22 Emisphere Technologies, Inc. Proteinoid microspheres and methods for preparation and use thereof
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
WO1992021659A1 (en) * 1991-05-28 1992-12-10 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative
EP0596126A4 (en) * 1991-12-27 1994-06-08 Wakunaga Seiyaku Kk Novel quinolone derivative or salt thereof and antibacterial containing the same.
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5811127A (en) 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
DE4232172A1 (de) * 1992-09-25 1994-03-31 Bayer Ag 7-(Aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)chinolon- und Naphthyridoncarbonsäure-Derivate
KR100236852B1 (ko) * 1992-10-09 2000-03-02 나가야마 오사무 플루오로 퀴놀린 유도체
US5401516A (en) * 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
EP0621267A1 (en) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidine derivatives and their use as fungicides
US5958457A (en) 1993-04-22 1999-09-28 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
ATE298561T1 (de) 1993-04-22 2005-07-15 Emisphere Tech Inc Orale dareichungsform
TW252107B (zh) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
WO1996022988A1 (fr) * 1995-01-24 1996-08-01 Hokuriku Seiyaku Co., Ltd. Derives de l'acide quiloleine carboxylique
US5965121A (en) 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6090958A (en) 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
BR9604880A (pt) 1995-03-31 1998-05-19 Emisphere Tech Inc Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
US5989539A (en) 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5820881A (en) 1995-04-28 1998-10-13 Emisphere Technologies, Inc. Microspheres of diamide-dicarboxylic acids
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US5824345A (en) 1995-06-07 1998-10-20 Emisphere Technologies, Inc. Fragrances and flavorants
US5667806A (en) 1995-06-07 1997-09-16 Emisphere Technologies, Inc. Spray drying method and apparatus
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
DE19681560T1 (de) 1995-09-11 1998-08-20 Emisphere Tech Inc Verfahren zur Herstellung von omega-Aminoalkansäure-Derivaten aus Cycloalkanonen
CA2258264A1 (en) 1996-06-14 1997-12-18 Emisphere Technologies, Inc. Microencapsulated fragrances and method for preparation
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US5876710A (en) 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US6060513A (en) 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5804688A (en) 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5939381A (en) 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5990166A (en) 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO1998049141A1 (en) * 1997-04-30 1998-11-05 Warner-Lambert Company Kappa opioid agonists
US5863944A (en) 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
KR100286874B1 (ko) 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
US8163769B2 (en) * 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
JP2006514964A (ja) * 2003-03-12 2006-05-18 アボット・ラボラトリーズ 抗菌剤としてのナフチリジン誘導体
WO2005026147A1 (ja) * 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体
US7977346B2 (en) * 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
US8222407B2 (en) * 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5872589A (ja) * 1981-10-28 1983-04-30 Dai Ichi Seiyaku Co Ltd ピリド〔１，２，３−ｄｅ〕〔１，４〕ベンゾオキサジン誘導体
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4929613A (en) * 1987-08-26 1990-05-29 Warner-Lambert Company Antibacterial agents
DE3814517A1 (de) * 1988-02-05 1989-08-17 Bayer Ag Chinolon- und naphthyridoncarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende antibakterielle mittel und futterzusatzstoffe
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
EP0447484A1 (en) * 1988-12-06 1991-09-25 The Upjohn Company Antibacterial quinolone compounds
US5276041A (en) * 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives

Also Published As

Publication number Publication date
WO1992010191A1 (en) 1992-06-25
US5137892A (en) 1992-08-11
NO932176D0 (no) 1993-06-14
IE914115A1 (en) 1992-06-17
AU9175991A (en) 1992-07-08
JPH05508868A (ja) 1993-12-09
NO932176L (no) 1993-06-14
JP2546769B2 (ja) 1996-10-23
EP0562042A1 (en) 1993-09-29
TW230774B (zh) 1994-09-21
EP0562042A4 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
NO305122B1 (no) AnalogifremgangsmÕte ved fremstilling av kinolin-, naftyridin- og pyridobenzoksazinderivater
NO864247L (no) Fremgangsmaate ved fremstilling av quinolinderivater.
NO885106D0 (no) FremgangsmŸte ved fremstilling av cytidin-derivater.
NO914809L (no) Fremgangsmaate ved fremstilling av celluloseformlegemer
YU27788A (en) Process for obtaining quinoline derivatives
NO180084C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO880068L (no) Fremgangsmaate ved fremstilling av heteroaryl-3-okso-propannitrilderivater.
ZA82740B (en) Novel sesquihydrate of naphthyridine derivative,and process for the preparation thereof
NO883392L (no) Fremgangsmaate ved fremstilling av tiometyl- og sulfinylmetylderivater.
ZA915567B (en) Process for the manufacture of quinoline derivatives
IL104137A (en) Process for the manufacture of 2-alkoxymethylacrolein compounds, their use for preparing 3-alkoxymethyl quinolines and 3-alkoxymethyl quinoline compounds
NO179517C (no) Fremgangsmåte for fremstilling av 8-klorkinolonderivater
NO882528L (no) Fremgangsmaate ved fremstilling av 2-metoksymetyl-penem-derivater.
HUP9900739A3 (en) Process for the preparation of quinoline derivatives, and the intermediates
HU901554D0 (en) Process for the preparation of quinoline derivatives
NO943071D0 (no) Fremgangsmåte ved fremstilling av 2,3,5,6-tetraklorpyridin
GB2051065B (en) Process for the preparation of indoline indole 1,2,3,4-tetrahydroquinoline quinoline and derivatives thereof
IL97807A0 (en) Process for preparing pyridine and quinoline derivatives
NO302416B1 (no) Fremgangsmåte for fremstilling av pergolid
NO881055D0 (no) Fremgangsmaate ved fremstilling av okso-isoindolinyl-derivater.
NO179041C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, racemiske eller optisk aktive isokinolinderivater
NO953459L (no) Fremgangsmåte ved fremstilling av cykloheptimidazolderivater
NO921389L (no) Fremgangsmaate for fremstilling av kinolinderivater
NO881709D0 (no) Fremgangsmaate ved fremstilling av nye dihydropyridinderivater.
NO911382L (no) Fremgangsmaate for fremstilling av pyridin- og kinolin-derivater.